Comments*

 
  • Life Sciences & Biomedical Research

  • Events 

    May 28 - 29, 2013 | Spain

    Advances in Plasmodium vivax Malaria Research

    Explore Plasmodium vivax biology and genomics; drug resistance and discovery; and recent clinical trial and in-field efforts in P. vivax malaria prevention, treatment, control, and elimination.

    Thursday, May 30, 2013 | 9:00 AM - 5:00 PM

    Assessing the Plasmodium vivax Research Agenda: Interdisciplinary Workshops

    Review progress on key aspects of the Plasmodium vivax research agenda as they pertain to malaria treatment, control, and elimination through a series of free, interdisciplinary workshops.

    Monday, June 3, 2013 | 1:00 PM - 4:00 PM

    Genome Integrity Discussion Group Meeting

    Organizers: John Petrini (Memorial Sloan-Kettering Cancer Center), Rodney Rothstein (Columbia University Medical Center), Lorraine Symington (Columbia University Medical Center)
    Keynote Speaker: Stephen West (London Research Institute, Cancer Research UK)

    The Genome Integrity Discussion Group provides a forum for interactions between basic and clinical research groups working on chromosome biology and function, and at the interface between chromosome integrity and onset and progression of malignancy.

    Wednesday, June 5, 2013 | 12:00 PM - 4:00 PM

    Chemical Biology Discussion Group Year-End Symposium

    Keynote Speaker: Alanna Schepartz (Yale University)
    Speakers: Han Guo (Luo lab, Memorial Sloan–Kettering Cancer Center), Rudy Jacquet (Montclare lab, NYU-Poly), Neel Shah (Muir lab, Princeton University), Monika Raj (Arora lab, NYU), Wenjiao Song (Jaffrey lab, Weill Medical College, Cornell University), and Carola Wilczek (Shechter lab, Albert Einstein College of Medicine)

    The Chemical Biology Discussion Group brings together chemists and biologists interested in discussing the latest breakthroughs. The year-end meeting features keynote speaker Professor Alanna Schepartz of Yale University and a poster session.

    Thursday, June 6, 2013 | 8:30 AM - 6:30 PM

    Capacity Building in Nutrition Science: Revisiting the Curricula for Medical Professionals

    Organizers: Sharon Akabas (Columbia University), Gerald Friedman (The Mount Sinai Hospital), Martin Kohlmeier (University of North Carolina), Charlotte Pratt (National Institute of Health), Gwen Twillman (American Society for Nutrition), Mandana Arabi (The Sackler Institute for Nutrition Science), Brooke Grindlinger (The New York Academy of Sciences)

    This conference aims to revisit the current nutrition curricula for health professionals and to explore how trainings can better provide the skills necessary for implementing the array of preventative and therapeutic nutrition interventions available. Presented as part of the Translational Medicine Initiative.

  • Past Events

    Friday, May 24, 2013 | 8:30 AM - 4:30 PM

    Targeting Epigenetic Regulators for Cancer Therapy

    Speakers: Scott A. Armstrong (Memorial Sloan-Kettering Cancer Center), Stephen Baylin (The Johns Hopkins University School of Medicine), Robert A. Copeland (Epizyme, Inc.), Vicki L. Goodman (GlaxoSmithKline), Haitao Li (Tsinghua University, China), X. Shirley Liu (Dana-Farber Cancer Institute), Robert Sims (Constellation Pharmaceuticals, Inc.), Alexander Tarakhovsky (The Rockefeller University)

    Epigenetic research has shown that heritable changes in cancer cell transformation occur beyond the primary DNA sequence. This symposium reviews epigenetic regulators in cancer development and progress in designing therapies targeting the epigenome.

    Friday, May 17, 2013 | 8:00 AM - 4:30 PM

    The Three Zeros of Eliminating HIV / AIDS: Global Science and Policy

    Speakers: Myron S. Cohen (UNC School of Medicine), Chris Collins (amfAR, The Foundation for AIDS Research), Michele R. Decker (Johns Hopkins Bloomberg School of Public Health), Tim Horn (Treatment Action Group), Rick King (IAVI), Luiz Loures (UNAIDS), Mary A. Marovich (NIAID), Nelson L. Michael (Walter Reed Army Institute of Research), Julio Montaner (BC Centre for Excellence in HIV / AIDS), John P. Moore (Weill Cornell Medical College), Robert R. Redfield (University of Maryland School of Medicine), Bill Snow (Global HIV Vaccine Enterprise), Magdalena Sobieszczyk (Columbia University Medical Center), Annie Sparrow (Mount Sinai Global Health), Daniel Tietz (ACRIA), Mitchell Warren (AVAC), Jane Waterman (IAVI)

    The UNAIDS "three zeros" strategy provides a clear vision for future HIV / AIDS research and policy. This symposium tackles communication and collaboration, capacity-building for HIV prevention, care, and treatment, vaccine trials and a case study.

    Monday, May 13, 2013 | 7:00 PM - 8:30 PM

    Social and Emotional Learning: Preparing Our Children to Excel

    Moderator: Ingrid Wickelgren (Scientific American Mind)
    Speakers: Clancy Blair (New York University), Amishi P. Jha (University of Miami)

    Join us to learn about the recent trends in education to foster social and emotional learning in classrooms is aimed at nurturing such fundamental traits as self-control, focus and perseverance in children.

    Monday, May 6, 2013 | 8:15 AM - 4:00 PM

    Translating Natural Products into Drugs for Alzheimer's and Neurodegenerative Disease

    Speakers: Kurt R. Brunden (University of Pennsylvania), Grant J. Carr (AMRI), Gabriela Chiosis (Memorial Sloan-Kettering Cancer Center), Jerold Chun (The Scripps Research Institute), Bonnie M. Davis (Synaptec), Chad Dickey (University of South Florida), Frank E. Koehn (Pfizer Global R&D), David J. Newman (National Cancer Institute, NIH), Salvatore Oddo (University of Texas Health Science Center, San Antonio), Giulio Maria Pasinetti (Mount Sinai School of Medicine)

    Alzheimer's disease may benefit from the novel chemistries found in natural products. This conference explores drug discovery from natural products, including novel approaches and technologies, and promising Alzheimer's drug discovery programs.

  • Publications 

    Annals

    The Year in Immunology: Basic and Clinical Research in Human Immunology

    Edited by Noel R. Rose (The Johns Hopkins University, Baltimore, Maryland)

    The fifth installment of The Year in Immunology series focuses on research in human immunology.

    Volume 1285

    eBriefing

    Health 2.0: Digital Technology in Clinical Care

    Organizers: Johanne Morne (New York State Department of Health AIDS Institute), Sonja Noring (New York State Department of Health AIDS Institute), Cheryl Smith (New York State Department of Health AIDS Institute), AIDS Institute Social Media Workgroup (New York State Department of Health AIDS Institute), Brooke Grindlinger (The New York Academy of Sciences), and Kerstin Hofmeyer (The New York Academy of Sciences)

    This eBriefing looks at the impact of digital technologies on clinical care, especially for HIV and other sexually transmitted infections, exploring eHealth strategies for patient-centered care and clinical decision support.

    Annals

    The Renaissance of Cancer Immunotherapy: The 7th International Cancer Vaccine Symposium

    Edited by Olivera J. Finn (University of Pittsburgh, Pittsburgh, Pennsylvania) and Gerold Schuler (University Hospital of Erlangen, Erlangen, Germany)

    This Annals volume presents papers that discuss progress of immunology research toward the development of cancer vaccines.

    eBriefing

    Sloth: Is Your City Making You Fat?

    Moderator: Tom Vanderbilt (Author)
    Panelists: Mariela Alfonzo (Polytechnic Institute at New York University), Kaid Benfield (Natural Resources Defense Council), and Hunter Reed (FAST NYC)

    As part of the Academy's Science and the Seven Deadly Sins series, a panel discussed urban design in NYC and explored how the built environment affects public health.

  • Podcasts

    Podcast
    April 14, 2011

    The Diabetes-Gum Disease Connection

    Good oral hygiene helps prevent tooth decay and gum disease, but the health of your mouth may have a big impact on the rest of your body too—especially if you have diabetes.

    Download (11 MB, 13:03)
    Podcast
    September 10, 2010

    What Makes Us Wise?

    Can we all be wise old owls? Science journalist Stephen Hall and neuroscientist Andre Fenton dissect what we call wisdom, from the neurons in our brain, to the social constructs behind it.

    Download (22 MB, 00:42:32)
    Podcast
    August 27, 2010

    Better Brains

    Neuroscientist Richard Restak thinks with the right mental exercises, our brains can be much better. Today he teams with writer Susan Orlean to talk about our brainy potential.

    Download (35 MB, 00:54:21)
    Podcast
    August 13, 2010

    How Prosperity Evolves

    With our economy a shambles and our environment threatened, is there any reason to be optimistic about the future? Matt Ridley says there's scientific proof to say we should be.

    Download (33 MB, 00:51:28)
  • Webinar Archives

    Webinar Archive
    March 2, 2010

    Emerging Infectious Diseases in Response to Climate Change

    Climate and weather are important components of complex ecosystems, and with these changes, the dynamic balance between the living components of ecosystems is often disturbed. Experts in climate change, climate policy, emerging infectious diseases and public health discussed the relevant and pressing issues that we as a global community face as the planet's climate is altered.

    Webinar Archive
    February 23, 2010

    Metabotropic Glutamate Receptors: Translation from Discovery to Clinical Trials

    Researchers met to discuss advances in basic and translational research on metabotropic glutamate receptors, which are promising targets in drug discovery for CNS diseases and other illnesses.

    Webinar Archive
    October 27, 2009

    Is Alzheimer's Disease Type 3 Diabetes?

    What is the connection between dysregulated neuronal insulin signaling and Alzheimer's disease? In a recent Academy webinar, some researchers argued that the neurodegenerative disease should be considered a type of diabetes.

    Webinar Archive
    April 28, 2009

    Protein Kinases: Structure-Guided Drug Discovery

    Protein kinases play a key role in almost every major pathway in eukaryotic cells. Structural approaches, including a new method called fragment-based drug design, are identifying potential targets against diseases including cancer.

  • Translational Medicine Initiative

    Macy FoundationThe Translational Medicine Initiative represents a three-year partnership between the New York Academy of Sciences and the Josiah Macy, Jr. Foundation to support the translation of basic science research into clinical applications.

    Learn more at www.nyas.org/TransMed.